These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 20541792

  • 1. Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review.
    Letchumanan P, Thumboo J.
    Semin Arthritis Rheum; 2011 Feb; 40(4):298-306. PubMed ID: 20541792
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid.
    Chan AY, Li EK, Tam LS, Cheng G, Choi PC.
    Rheumatol Int; 2005 Jun; 25(5):388-90. PubMed ID: 15565448
    [Abstract] [Full Text] [Related]

  • 3. Danazol for thrombocytopenia in pregnancy with underlying systemic lupus erythematosus.
    Insiripong S, Chanchairujira T, Bumpenboon T.
    J Med Assoc Thai; 1996 May; 79(5):330-2. PubMed ID: 8708526
    [Abstract] [Full Text] [Related]

  • 4. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome.
    Cervera H, Jara LJ, Pizarro S, Enkerlin HL, Fernandez M, Medina F, Fraga A, Miranda JM.
    J Rheumatol; 1995 Oct; 22(10):1867-71. PubMed ID: 8991983
    [Abstract] [Full Text] [Related]

  • 5. Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    Chan AC, Sack K.
    J Rheumatol; 1991 Feb; 18(2):280-2. PubMed ID: 2023224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.
    West SG, Johnson SC.
    Ann Intern Med; 1988 May; 108(5):703-6. PubMed ID: 3358571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases.
    Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Sanchez-Andrade A, González-Gay MA.
    Br J Rheumatol; 1997 Oct; 36(10):1095-9. PubMed ID: 9374927
    [Abstract] [Full Text] [Related]

  • 10. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.
    Agnello V, Pariser K, Gell J, Gelfand J, Turksoy RN.
    J Rheumatol; 1983 Oct; 10(5):682-7. PubMed ID: 6606038
    [Abstract] [Full Text] [Related]

  • 11. Danazol in the treatment of a systemic lupus erythematosus (SLE)-like illness associated with deficiency of the fourth component of complement.
    Petrovsky N.
    Aust N Z J Med; 1997 Apr; 27(2):189. PubMed ID: 9145187
    [No Abstract] [Full Text] [Related]

  • 12. Salvage therapy and long-term remission with danazol and cyclosporine in refractory Evan's syndrome.
    Chemlal K, Wyplosz B, Grange MJ, Lassoued K, Clauvel JP.
    Am J Hematol; 1999 Nov; 62(3):200. PubMed ID: 10539891
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
    Zandman-Goddard G, Levy Y, Shoenfeld Y.
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
    Mok CC.
    Scand J Rheumatol; 2007 Dec; 36(5):329-37. PubMed ID: 17963161
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Systemic lupus erythematosus: two patients treated with danazol.
    Morley KD, Parke A, Hughes GR.
    Br Med J (Clin Res Ed); 1982 May 15; 284(6327):1431-2. PubMed ID: 6805552
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Chang HK.
    J Korean Med Sci; 2005 Oct 15; 20(5):883-5. PubMed ID: 16224167
    [Abstract] [Full Text] [Related]

  • 19. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Mok CC, Ying SK, Ma KM, Wong CK.
    Lupus; 2013 Dec 15; 22(14):1470-8. PubMed ID: 24113197
    [Abstract] [Full Text] [Related]

  • 20. Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review.
    Huang HE, Lin KM, Lin JC, Lin YT, He HR, Wang YW, Yu SF, Chen JF, Cheng TT.
    Pharmaceuticals (Basel); 2022 Nov 09; 15(11):. PubMed ID: 36355549
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.